Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab

Neurology

Volumn 77, Issue 5, 2011, Pages 505-507

  Stosic, M ^a   De Jesus, P ^a   McCarthy, J ^b   Hutton, G ^a   Rivera, V ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BETA1A INTERFERON; NATALIZUMAB; PREDNISONE;

ADULT; AFRICAN AMERICAN; ANEMIA; ARM; ARTICLE; BLEPHAROSPASM; BLOOD CELL COUNT; BLOOD EXAMINATION; BLURRED VISION; BRAIN DAMAGE; CASE REPORT; CONTRAST ENHANCEMENT; DEPRESSION; DRUG WITHDRAWAL; ECCHYMOSIS; FATIGUE; FEMALE; FLU LIKE SYNDROME; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LEG; MENSTRUATION; MOUTH MUCOSA; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; PARESTHESIA; PATIENT COMPLIANCE; PETECHIA; PONS; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SKIN BRUISING; SPINAL CORD LESION; THROMBOCYTE COUNT; TIC;

EID: 80051483071     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318227b23f     Document Type: Article

References (2)

1. CAMMS223 Trial Investigators, Coles AJ, Compston DA, et al. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med 2008;359:1786-1801.
2. Aster RH, Curtis BR, McFarland JG, et al. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 2009;7:911-918.